GlaxoSmithKline announced that the FDA has approved FluLaval Quadrivalent influenza Virus Vaccine for the active immunization of persons three years...
Glaxo Smith Kline has recalled doses of its FluLaval Quadrivalent flu vaccine due to effectiveness problems. GSK has announced that...
GlaxoSmithKline has announced the submission of a supplemental Biologics License Application (sBLA) to the FDA for Flulaval Quadrivalent (Influenza Vaccine)....
The FDA has approved Fluarix Quadrivalent Influenza Virus Vaccine from Glaxo Smith Kline, for the immunisation of children (three years...
The FDA has approved Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (also referred to as Q-Pan H5N1 influenza vaccine), from...
The FDA has approved FluMist Quadrivalent,from Medimmune a vaccine to prevent seasonal influenza in people ages 2 years through 49...
The FDA has approved its quadrivalent formulation of Flublok influenza vaccine, from Protein Sciences Corporation. Flublok Quadrivalent protects against 4...
Sanofi Pasteur, has announced that the FDA has approved the supplemental biologics license application (sBLA) for licensure of its four-strain...
Protein Sciences Corporation announced topline data showing that Flublok Quadrivalent � the quadrivalent version of FDA-approved trivalent Flublok influenza vaccine...
The FDA has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine), from Sanofi, for use in...